PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
14566196-3	2003	Paroxetine also has been shown to be a potent and selective inhibitor of the human serotonin transporter (SERT) and has recently been demonstrated to have moderate affinity for the norepinephrine transporter (NET).	Paroxetine	0-10	solute carrier family 6 member 4	Homo sapiens	83-104	
14566196-3	2003	Paroxetine also has been shown to be a potent and selective inhibitor of the human serotonin transporter (SERT) and has recently been demonstrated to have moderate affinity for the norepinephrine transporter (NET).	Paroxetine	0-10	solute carrier family 6 member 4	Homo sapiens	106-110	
14566196-7	2003	Paroxetine administration in laboratory animals has been shown to be associated with decreased SERT density and function, maintenance of normal firing rates and release of 5-HT, and increased activation of postsynaptic 5-HT receptors.	Paroxetine	0-10	solute carrier family 6 member 4	Homo sapiens	95-99	
14566196-9	2003	At usual clinical doses (ie, 20 mg/d), paroxetine is a potent and selective inhibitor of the SERT; however, at higher doses (ie, 40 mg/d), paroxetine can exhibit marked NET inhibition.	Paroxetine	39-49	solute carrier family 6 member 4	Homo sapiens	93-97